Class IITerminatedVoluntary: Firm initiated

Gospodarstwo Pasieczne Sadecki Bartnik: food recall H-0012-2026

Gospodarstwo Pasieczne Sadecki Bartnik of Grybow recalled Sadecki Bartnik Pylek Kwiatowy (Bee Pollen) 200g (7.05oz) glass jar UPC 5 900597 000788. Reason: detectable pyrrolizidine alkaloids. The FDA listed it as Class II in its Enforcement Report dated Oct 15, 2025; distribution: Illinois.

Record status as published: Terminated (terminated Nov 12, 2025). openFDA data last updated Oct 21, 2026.

Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.

Recall details

Product
Sadecki Bartnik Pylek Kwiatowy (Bee Pollen) 200g (7.05oz) glass jar UPC 5 900597 000788
Product quantity
336 jars
Reason for recall
detectable pyrrolizidine alkaloids
Codes, lots and dates on the package
13/12/2026 1/1
Distribution pattern
IL
Recalling firm
Gospodarstwo Pasieczne Sadecki Bartnik, Grybow, Poland
Classification
Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Voluntary or mandated
Voluntary: Firm initiated
How the firm first notified customers
Telephone

Dates

EventDate
Recall initiated by the firmSep 4, 2025
Classified by the FDAOct 3, 2025
Published in the Enforcement ReportOct 15, 2025
TerminatedNov 12, 2025

All food recall records

OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.

Sources

  • U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0012-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
  • Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.